MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

CVS Health Corp.

Slēgts

SektorsVeselības aprūpe

65.87 0.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

65.19

Max

65.99

Galvenie mērījumi

By Trading Economics

Ienākumi

1.5B

1.6B

Pārdošana

2.3B

98B

P/E

Sektora vidējais

17.806

57.333

EPS

1.19

Dividenžu ienesīgums

4.08

Peļņas marža

1.661

Darbinieki

219,000

EBITDA

811M

4B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+15.07% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

4.08%

2.63%

Nākamie ieņēmumi

2025. g. 1. maijs

Nākamais dividenžu datums

2025. g. 1. maijs

Nākamais Ex dividenžu datums

2025. g. 21. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

14B

85B

Iepriekšējā atvēršanas cena

65.53

Iepriekšējā slēgšanas cena

65.87

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 8. apr. 11:27 UTC

Top Ziņas

CVS Health Taps Brian Newman to CFO Position; Expects to Meet, Beat Fiscal Year Guidance

2025. g. 7. apr. 23:45 UTC

Karstas akcijas

Stocks to Watch: CVS Health, UnitedHealth Group, Spire Global, Pacira BioSciences

2025. g. 7. apr. 21:36 UTC

Galvenie tirgus virzītāji

Medicare Insurer Shares Rise on Plans for Higher Payment Rates

2025. g. 12. febr. 16:17 UTC

Peļņas
Galvenie tirgus virzītāji

CVS Stock Rises on Better-than-Feared Results, Outlook

2025. g. 17. apr. 13:38 UTC

Peļņas

UnitedHealth Stock Sinks 18% After Earnings. Medicare Advantage Is an Issue. -- Barrons.com

2025. g. 17. apr. 11:20 UTC

Peļņas

UnitedHealth Stock Sinks 20% on Earnings Miss and Guidance Cut. Medicare Advantage Is an Issue. -- Barrons.com

2025. g. 17. apr. 10:46 UTC

Peļņas

UnitedHealth Stock Sinks 19% on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 17. apr. 10:40 UTC

Peļņas

UnitedHealth Stock Sinks 19% on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 17. apr. 10:15 UTC

Peļņas

UnitedHealth Stock Sinks on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 8. apr. 11:12 UTC

Top Ziņas

CVS Health Taps Brian Newman to CFO Position; Expects to Meet, Beat FY Guidance

2025. g. 7. apr. 22:18 UTC

Top Ziņas

Health Insurer Stocks Jump After Medicare Boosts Payment Rates -- Barrons.com

2025. g. 7. apr. 20:15 UTC

Top Ziņas

Private Medicare Plans to Get Big Payment Boost From Trump Administration -- WSJ

2025. g. 2. apr. 18:20 UTC

Top Ziņas

Trump's Move to Dump FTC's Democratic Members Leaves Insulin Case in Limbo -- WSJ

2025. g. 2. apr. 16:53 UTC

Top Ziņas

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

2025. g. 8. marts 10:30 UTC

Top Ziņas

CVS Health Preparing to Open Small Stores With Full-Service Pharmacies, Limited Retail -- WSJ

2025. g. 4. marts 17:02 UTC

Iegādes, apvienošanās, pārņemšana

Wellvana, CVS Health Didn't Disclose Detailed Terms >CVS

2025. g. 4. marts 17:01 UTC

Iegādes, apvienošanās, pārņemšana

Wellvana Acquired Medicare Shared Savings Program Business of CVS Accountable Care in All-Stk Transaction >CVS

2025. g. 4. marts 17:00 UTC

Iegādes, apvienošanās, pārņemšana

CVS Health Gets a Strategic Minority Investment in Wellvana >CVS

2025. g. 4. marts 17:00 UTC

Iegādes, apvienošanās, pārņemšana

Wellvana Acquires CVS Health's MSSP Business CVS

2025. g. 21. febr. 18:22 UTC

Top Ziņas

It's No Longer Business as Usual for UnitedHealth, or the Entire Healthcare Industry -- Heard on the Street -- WSJ

2025. g. 12. febr. 15:24 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 14:22 UTC

Peļņas

CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25 -- IBD

2025. g. 12. febr. 13:58 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 12:16 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 12. febr. 12:07 UTC

Tirgus saruna
Peļņas

CVS Stock Jumps After Beating 4Q Forecasts -- Market Talk

2025. g. 12. febr. 11:55 UTC

Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 12. febr. 11:31 UTC

Peļņas

CVS Offers Some Assurance to Investors for 2025 -- WSJ

2025. g. 12. febr. 11:30 UTC

Peļņas

CVS Health 4Q Health Services Segment Revenue $47.02B >CVS

2025. g. 12. febr. 11:30 UTC

Peļņas

CVS Health 4Q Pharmacy & Consumer Wellness Segment Revenue $33.51B >CVS

2025. g. 12. febr. 11:30 UTC

Peļņas

CVS Health 4Q Healthcare Benefits Segment Revenue $32.96B >CVS

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

15.07% augšup

Prognoze 12 mēnešiem

Vidējais 75.45 USD  15.07%

Augstākais 90 USD

Zemākais 59 USD

Pamatojoties uz 21 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

21 ratings

18

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

64.45 / 68.3394Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Neutral Evidence

Ilgtermiņā

Bullish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.